Blog

Bloomberg Interviews Michael Wynne on Bristol Myers Deferred Adjudication

Bristol-Myers Squibb Company is an American pharmaceutical company that manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

The company was involved in an accounting scandal in 2002 that resulted in a significant restatement of revenues from 1999 to 2001.

The company entered into deferred adjudication with the U.S. Department of Justice and Securities and Exchange Commission, agreeing to pay $150 million while neither admitting nor denying guilt.

Bloomberg interviewed former U.S. Attorney Michael J. Wynne in 2006 regarding the Bristol Myers deferred adjudication.

Recent blog posts

Wynne Talks to KPRC on Houston Mayor’s Alleged Bribe Acceptance

KPRC Houston is investigating an email train possibly indicated that the mayor of Houston, Sylvestor Turner, accepted bribes. On Aug. 11, 2017, Yoo emailed Andy Icken, Houston’s chief development officer, and William Paul Thomas, director...

Read More +

KPRC Investigates Whether Harris County Taxpayers Are Funding Commissioner’s Campaign Vehicle

Harris County commissioner Rodney Ellis hasn't launched a re-election campaign, yet is reportedly using campaign contributions from donors to fly business class internationally, according to KPRC 2 Investigates. Texas' election code states that politicians can't...

Read More +

Wynne Works on Case to Overturn Murder Conviction Based on Recanted Witness Testimony

Attorney Michael J. Wynne is part of the legal team working to appeal a conviction in a 1997 Houston murder, where new evidence recently came to light. Lamar Burks has served 19 years in prison...

Read More +

Contact Us

Get powerful legal representation. Contact Michael J. Wynne to begin your defense now.

123